Navigation Links
New leads on mechanisms that confer virulence to E.coli-type bacteria

The researchers have solved the three-dimensional structure of a key region of the DNA-protein complex. Knowledge about the structures that control the activity of genes associated with virulence and resistance to antibiotics is crucial to understand the molecular mechanisms that regulate bacterial pathogenicity and to pave the way for alternative treatments to conventional antibiotics. According to Jess Garca, research associate in the IRB Barcelona group headed by Miquel Pons, researcher at IRB Barcelona and professor of the UB, "a strategy based on selective regulatory systems for genes responsible for virulence is particularly attractive because it could potentially minimize the adverse effects on our bacterial flora and reduce the selective pressure for the development of antibiotic resistance in bacteria".

Many of the genes responsible for pathogenic bacteria virulence and resistance to antibiotics have been acquired through processes such as horizontal gene transfer (HGT). By means of this mechanism, bacteria incorporate genetic material from external sources such as bacteria or phages (viruses that affect bacteria). The correct regulation of HGT genes, in other words silencing when not required and coordinated activation to produce a beneficial effect, is crucial for the success of bacteria.

"The resolved structure has allowed us to understand the way in which Ler recognizes its DNA binding sites. Ler does not recognize specific sequences but local DNA structures. In our study we also tested whether this recognition mode is used by other proteins of the same family, such as H-NS", explains Garca. The Ler and H-NS proteins play a critical role in the regulation of genes acquired through HGT in pathogenic E. coli strains.

Contact: Snia Armengou
Institute for Research in Biomedicine (IRB Barcelona)

Page: 1

Related biology news :

1. FSU researchers discovery leads to $1.5 million grant, potential new treatment of liver fibrosis
2. How neuronal activity leads to Alzheimers protein cleavage
3. Exposing chicks to maternal stress leads to long-term reproductive success
4. TECNALIA leads five projects within the VII Framework Program
5. Personalized medicine: Innovative online journal leads the way
6. Mayo Clinic research on tamoxifen leads to recommendation for CYP2D6 gene test
7. Study of placenta unexpectedly leads to cancer gene
8. Game of two halves leads to brain asymmetry
9. Transportation fuels of the future: Nottingham leads the way
10. Concordia University leads academic team for national Cellulosic Biofuels Network
11. Elephant shark genome sequence leads to discovery of color perception in deep-sea fish
Post Your Comments:
Related Image:
New leads on mechanisms that confer virulence to E.coli-type bacteria
(Date:4/15/2016)... , April 15, 2016  A new ... make more accurate underwriting decisions in a fraction ... timely, competitively priced and high-value life insurance policies ... screenings. With Force Diagnostics, rapid testing ... lifestyle data readings (blood pressure, weight, pulse, BMI, ...
(Date:4/13/2016)... physicians supporting Medicaid patients in Central Florida ... telehealth thanks to a new partnership with higi.   ... can routinely track key health measurements, such as blood ... they opt in, share them with IMPOWER clinicians through ... location at no cost. By leveraging this data, IMPOWER ...
(Date:3/29/2016)... Florida , March 29, 2016 ... the "Company") LegacyXChange "LEGX" and SelectaDNA/CSI Protect are pleased ... in ink used in a variety of writing instruments, ... Buyers of originally created collectibles from athletes on LegacyXChange ... forensic analysis of the DNA. Bill ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... ... June 23, 2016 , ... ... of its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with ... in this eBook by providing practical tips, tools, and strategies for clinical researchers. ...
(Date:6/23/2016)... /PRNewswire/ - FACIT has announced the creation of ... company, Propellon Therapeutics Inc. ("Propellon" or "the Company"), ... portfolio of first-in-class WDR5 inhibitors for the treatment ... represent an exciting class of therapies, possessing the ... cancer patients. Substantial advances have been achieved with ...
(Date:6/23/2016)... ... 23, 2016 , ... Charm Sciences, Inc. is pleased to ... AOAC Research Institute approval 061601. , “This is another AOAC-RI approval of the ... Vice President of Regulatory and Industrial Affairs. “The Peel Plate methods perform comparably ...
(Date:6/23/2016)... 23, 2016   EpiBiome , a precision microbiome ... in debt financing from Silicon Valley Bank (SVB). The ... to advance its drug development efforts, as well as ... "SVB has been an incredible strategic partner to ... traditional bank would provide," said Dr. Aeron Tynes ...
Breaking Biology Technology: